SCHEMBL10023974

SCHEMBL10023974

CCCc1ccc(N(c2ccccc2)c2ccc(C=O)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
ALDH3A1 P30838 1/20 0.50
ALDH1A3 P47895 1/20 0.50
CYP2A6 P11509 2/20 0.44
CYP2A13 Q16696 1/20 0.44
GLA P06280 1/20 0.41
TSHR P16473 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
CHRM1 P11229 1/20 0.40
DRD1 P21728 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
ADRA1A P35348 1/20 0.40
OPRM1 P35372 1/20 0.40
DRD3 P35462 1/20 0.40
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11887470 0.92 ALDH1A1 (0.46) ALDH1A1ALDH3A1ALDH1A3CYP2A6CYP2A13
SCHEMBL24478976 0.88 KCNH2 (0.51) ALDH1A1ALDH3A1ALDH1A3CHRM2ADRA2A
SCHEMBL2410952 0.88 KCNH2 (0.51) ALDH1A1ALDH3A1ALDH1A3CHRM2ADRA2A
SCHEMBL10068360 0.87 CYP2A6 (0.53) ALDH1A1ALDH3A1ALDH1A3CYP2A6CYP2A13
SCHEMBL7750599 0.86 ALDH1A1 (0.53) ALDH1A1ALDH3A1ALDH1A3CYP2A6CYP2A13
SCHEMBL10023973 0.86 LPL (0.48) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL11887109 0.86 LPL (0.48) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL11887475 0.85 ALDH1A1 (0.49) ALDH1A1ALDH3A1ALDH1A3CYP2A6CYP2A13
SCHEMBL14003991 0.85 RELA (0.52) ALDH1A1MAPTLPLLIPGAPP
SCHEMBL13701305 0.84 ALDH1A1 (0.41) ALDH1A1ALDH3A1ALDH1A3CYP2A6CYP2A13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673523-B2 Image holding member for image forming apparatus, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2014-03-18 US disclosed
US-8664645-B2 Organic electroluminescence element and display medium FUJI XEROX CO., LTD. (JP) 2014-03-04 US disclosed
US-8475981-B2 Image holding member for image forming apparatus, process cartridge, and image forming apparatus FUJI XEROX, CO., LTD. (JP) 2013-07-02 US disclosed
US-20120232242-A1 THIAZOLOTHIAZOLE COMPOUND AND THIAZOLOTHIAZOLE POLYMER FUJI XEROX CO., LTD. (JP) 2012-09-13 US disclosed
US-20120187384-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND DISPLAY MEDIUM FUJI XEROX CO., LTD. (JP) 2012-07-26 US disclosed
US-8207348-B2 Thiazolothiazole compound and thiazolothiazole polymer FUJI XEROX CO., LTD. (JP) 2012-06-26 US disclosed
US-20120015290-A1 IMAGE HOLDING MEMBER FOR IMAGE FORMING APPARATUS, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2012-01-19 US disclosed
US-20110207040-A1 IMAGE HOLDING MEMBER FOR IMAGE FORMING APPARATUS, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2011-08-25 US disclosed
US-20110086999-A1 THIAZOLOTHIAZOLE COMPOUND AND THIAZOLOTHIAZOLE POLYMER FUJI XEROX CO., LTD. (JP) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086999-A1 THIAZOLOTHIAZOLE COMPOUND AND THIAZOLOTHIAZOLE POLYMER ARL1, IRAK1, TYK2 ALDH1A1 193/4885ALDH3A1 1243/4885ALDH1A3 1814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.